SCHEMBL30125599

SCHEMBL30125599

COC(=O)CCNC(=O)c1nc(NC(=O)c2nc(N)cn2C)cn1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.38
HDAC2 Q92769 2/20 0.38
HDAC8 Q9BY41 2/20 0.38
KDM5B Q9UGL1 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.32
ALDH1A1 P00352 1/20 0.32
VDR P11473 1/20 0.32
HRAS P01112 1/20 0.32
ESR1 P03372 1/20 0.32
TOP1 P11387 1/20 0.32
ESR2 Q92731 1/20 0.32
MAPT P10636 2/20 0.32
CNR1 P21554 1/20 0.32
CNR2 P34972 1/20 0.32
P2RX3 P56373 1/20 0.32
KDM4E B2RXH2 1/20 0.31
POLB P06746 1/20 0.31
HIF1A Q16665 1/20 0.31
RPS6KA2 Q15349 2/20 0.31
MTOR P42345 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22824758 0.92 KDM5B (0.38) KDM5BSMN1; SMN2ALDH1A1MAPTP2RX3
SCHEMBL30125575 0.86 HDAC1 (0.52) HDAC1HDAC2HDAC8HRASESR1
SCHEMBL23745100 0.86 HDAC1 (0.56) HDAC1HDAC2HDAC8HRASESR1
Hydrochloric Acid SCHEMBL8894664 0.85 KDM4E (0.46) HDAC1HDAC2HDAC8HRASESR1
SCHEMBL30125639 0.84 HDAC1 (0.43) HDAC1HDAC2HDAC8KDM5BSMN1; SMN2
SCHEMBL30125658 0.84 NAMPT (0.40) HDAC1HDAC2HDAC8KDM5BSMN1; SMN2
SCHEMBL23744918 0.84 HDAC1 (0.42) HDAC1HDAC2HDAC8KDM5BSMN1; SMN2
SCHEMBL30125666 0.83 HDAC1 (0.37) HDAC1HDAC2HDAC8KDM5BALDH1A1
Hydrochloric Acid SCHEMBL28984120 0.83 HDAC1 (0.41) HDAC1HDAC2HDAC8KDM5BSMN1; SMN2
SCHEMBL31180736 0.81 HDAC1 (0.42) HDAC1HDAC2HDAC8KDM5BSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240360105-A1 PROCESS FOR POLYAMIDE SYNTHESIS Design Therapeutics, Inc. 2024-10-31 US disclosed
EP-4384506-A1 PROCESS FOR POLYAMIDE SYNTHESIS Design Therapeutics, Inc. (US) 2024-06-19 EP disclosed
WO-2023014793-A1 PROCESS FOR POLYAMIDE SYNTHESIS Design Therapeutics, Inc. (US) 2023-02-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240360105-A1 PROCESS FOR POLYAMIDE SYNTHESIS POLI, POLR2A, POLR2B HDAC1 489/4885HDAC2 551/4885HDAC8 156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.